New research has identified a previously unknown mechanism involved in the immune response that could provide an alternative therapy target for treating the estimated 1.5 million Americans and five million-plus people worldwide suffering from lupus.
New research has identified a previously unknown mechanism involved in the immune response that could provide an alternative therapy target for treating the estimated 1.5 million Americans and five million-plus people worldwide suffering from lupus.